MENU
MLYS
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Mineralys Therapeutics (MLYS) Ownership - Who owns Mineralys Therapeutics?
Profile
Industry
N/A
Address
150 North Radnor Chester Road
Phone
+1 888 378-6240
Employees
28
Web
https://mineralystx.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
619.1M
P/E Ratio
N/A
Total Cash
311.12M
Projected Growth
N/A
Total Debt
N/A
Revenue
N/A
Risk (Beta)
N/A
Dividend Yield
N/A
Total Cash/Share
6.26
Total Debt/Equity
N/A
Revenue/Share
null USD as % of share price
Fundamentals
MLYS
Capitalization
619M
P/E Ratio
N/A
Risk (Beta)
N/A
Dividend Yield
N/A
Total Cash
311M
Total Cash/Share
6.26
Total Debt
N/A
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0%
Revenue
0
ROE
N/A
Book Value
290M
P/B Ratio
2.13
Cash Flow
N/A
Earnings
-2.76
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
5K
Current Ratio
11.20
Current Revenue Per Employee
N/A
Dividends Per Share - Security
N/A
EBITDA
-134.51M
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
-39.26
Shares Held By Institutions
663M
Shares Outstanding - Current
49.7M
Total Liabilities
28.4M
Total Volume MTD
N/A
Value
1
Gain YTD
44.767
View a ticker or compare two or three
VS
VS
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
Industry Biotechnology
Profile
Fundamentals
Details
Industry
N/A
Address
150 North Radnor Chester Road
Phone
+1 888 378-6240
Employees
28
Web
https://mineralystx.com